Report Type: Therapy Reports
Report Category: Oncology
Report Subcategory: Lymphoma
Price: $ 2999.00
Date: July 2021

Lymphoma Global Market Landscape till 2030: Epidemiology, Drugs, Trials, Technology, Companies, News, Deals, Patents, Drug Sales & Forecast, Future Events, DMF, and Manufacturing

Lymphoma:

Lymphoma is a cancer of the lymphatic system, which is part of the body's germ-fighting network.
The main subtypes are:

Hodgkin's lymphoma (formerly called Hodgkin's disease)
Non-Hodgkin's lymphoma
Top & Promising Drugs by Company:    
Bristol-Myers Squibb Co- Revlimid (lenalidomide)
F. Hoffmann-La Roche Ltd- Rituxan (rituximab)
AbbVie Inc- Imbruvica (ibrutinib)
AstraZeneca Plc- Calquence (acalabrutinib maleate)
TG Therapeutics Inc- ublituximab and umbralisib tosylate
BeiGene Ltd- Brukinsa (zanubrutinib)
F. Hoffmann-La Roche Ltd- Gazyva  (obinutuzumab)
Takeda Pharmaceutical Co Ltd- Velcade (bortezomib)
Bristol-Myers Squibb Co- Breyanzi (lisocabtagene maraleucel)
F. Hoffmann-La Roche Ltd- Polivy (polatuzumab vedotin)